Tirzepatide formulations that include additional compounds like glycine and B12 , niacinamide , or levocarnitine introduce additional variables that may affect local tolerability
When we eat, GLP-1 is released, signaling our brain to reduce hunger and make us feel full
Archived from the original on June 30, 2022
Alternative causes such as anaemia, thyroid disease, or vitamin B12 deficiency should also be considered
Although Clostridia can redirect metabolic pathways to shift carbon and energy metabolism toward those with higher oxygen tolerance, such metabolic rewiring has a high probability of impairing the performance of engineered strains, resulting in a decrease in the yield of the intended target product
Current clinical trials and future studies should take into account gender-dependent factors, receptor polymorphism, and the selectivity of brain regions in order to optimize the translational potential of this strategy [114]